MetaCap

Celularity Statistics

NASDAQ: CELUHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.463-0.0049 (-1.05%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Celularity by the numbers

Celularity has a market capitalization of $15.0 million based on 32.45M shares outstanding. With trailing EPS of $-1.69, Celularity is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 57.2% below its 50-day average and 55.6% below its 200-day average.

Average daily trading volume is 3.95M shares, or about $1.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CELU valuation vs. peer median

CELU compared with the median of 8 peer companies
MetricCELUPeer medianDifference
Market cap$15.02M$15.78M-5%
Avg. volume3.95M171.72K+2202%

Peer median across 8 companies: CNTX, NCEL, QNRX, PBM, ATOS, LPCN, CTXR, SHPH.

Valuation

Market cap
$15.02M
Price / sales (latest FY)
0.57
EPS (TTM)
$-1.69

Price and trading

Previous close
0.4679
Open
0.4999
Day range
0.4202 – 0.4999
52-week range
0.42 – 2.55
52-week change
-73.54%
Beta
—
Volume
295.91K

Dividends and events

Annual dividend
None
Next earnings date
Aug 18, 2025

Additional statistics

Market Cap
15.02M
Forward Pe
-0.81
Eps
-1.69
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
2.55
Week52 Low
0.42
Avg Volume
3.95M
Shares Outstanding
32.45M
Ma50
1.08
Ma200
1.04
Earnings Date
Aug 18, 2025
Pct From52w High
-81.84%
Pct From52w Low
10.24%

Related